Your Location:
Home >
Browse articles >
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies
RESEARCH | Updated:2025-12-13
    • MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies

    • In the field of liver cancer treatment, researchers have made significant progress. They found that radiofrequency ablation (RFA) treatment upregulated MELK expression, and MELK inhibition promoted RFA efficacy by immunogenic cell death and the antitumor response. Targeting MELK via RGD-LNPs provides new insight into improving RFA efficacy in HCC clinical treatment and combating the malignant progression of liver cancer.
    • Military Medical Research   Vol. 12, Issue 7, Pages: 1046-1064(2025)
    • DOI:10.1186/s40779-024-00588-7    

      CLC:
    • Published:2025-07

    Scan QR Code

  • Cite this article as: Tang BF, Xu WT, Fang SJ, Zhu JY, Qiu RF, Shen L, et al. MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. Mil Med Res. 2025;12(1):5. DOI: 10.1186/s40779-024-00588-7.

  •  
  •  

0

Views

0

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity
mRNA vaccine development for cholangiocarcinoma: a precise pipeline
New Calculation Method of Water Inflow Quantity in Wulong Tunnel on Chongqing--Huaihua Railway
Research on Reinforcement Technique to Enhance Lateral Stiffness of Steel Truss Bridge on Existing Railway
Analysis on the Reason of Larger Wheel/Rail Lateral Force for Loaded Car with 3D-axle Welded-frame Bogies during Negotiating

Related Author

Guo-Hui Liu
Yuan Xiong
Bo-Bin Mi
Ze Lin
Yi-Qiang Hu
Le Yu
Kang-Kang Zha
Adriana C. Panayi

Related Institution

Harvard Stem Cell Institute, Harvard University
Skeletal Biology Laboratory, Department of Orthopedic Surgery, Brigham and Women’s Hospital, Harvard Medical School
Joint Laboratory of Optofluidic Technology and System, National Center for International Research on Green Optoelectronics, South China Academy of Advanced Optoelectronics, South China Normal University
Department of Physics, Center for Hybrid Nanostructure (CHyN), University of Hamburg
Department of Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
0